Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Sep 2;107(10):1357–1362. doi: 10.1111/cas.13011

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Strategy of early detection and pre‐emptive therapy for pancreatic cancer. To improve the current poor prognosis of pancreatic cancer, high‐risk groups of pancreatic cancer should be defined using a combination of several kinds of biomarkers and ultrasonography. Pre‐emptive medicine is an ideal tool to prevent pancreatic cancer. Although distant metastasis cannot be identified using image diagnosis such as computed tomography, MRI, or PET, dramatic increases in Aleuria aurantia lectin (AAL)‐reactive fucosylated haptoglobin (Fuc‐Hpt) might be an indication that therapies other than surgical operation are needed. MRCP, magnetic resonance cholangiopancreatography; PhoSL, Pholiota squarrosa lectin.